Home › Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...
 

Keywords :   


Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...

2014-11-04 04:36:32| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- --Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTATM , a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA's review process.

Tags: european swedish announce medicines

Category:Consumer Goods and Services

Latest from this category

All news
22.11'Scammers sent courier to steal 4,000'
22.11Spain fines budget airlines including Ryanair 179m
22.11Formulating Biphasic and Triphasic Products
22.11Gatwick terminal evacuated due to security risk
22.1168% of US households have a smart TV, 46% have a streaming media player
22.11Reliance and Disney complete India JV transaction
22.11HbbTV Association appoints Service List Registry
22.11ocilion brings Prime Video and YouTube to its IPTV platform
Consumer Goods and Services »
23.11
23.11 WEEZER / maladroit 12\"
23.11
23.11 6'1ML REV-S
23.11speak up storys
23.11190mm LS0713FL
23.11That's Moulton
23.11SEED
More »